Production (Stage)
Fractyl Health, Inc.
GUTS
$2.17
-$0.10-4.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -57.14% | -61.11% | -40.28% | 560.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -57.14% | -61.11% | -40.28% | 560.00% |
| Cost of Revenue | -- | -100.00% | -72.00% | -48.94% | 533.33% |
| Gross Profit | -- | -40.00% | -36.36% | -24.00% | 600.00% |
| SG&A Expenses | -25.35% | 74.89% | 6.55% | 126.24% | 158.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.76% | 94.13% | 71.17% | 92.75% | 78.13% |
| Operating Income | -14.93% | -94.21% | -71.51% | -93.56% | -77.93% |
| Income Before Tax | -614.48% | -30.19% | -47.16% | 43.01% | 72.16% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -614.48% | -30.19% | -47.16% | 43.01% | 72.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -614.48% | -30.19% | -47.16% | 43.01% | 72.16% |
| EBIT | -14.93% | -94.21% | -71.51% | -93.56% | -77.93% |
| EBITDA | -13.87% | -93.05% | -71.04% | -93.28% | -79.16% |
| EPS Basic | -185.54% | 95.39% | 94.97% | 97.84% | 97.84% |
| Normalized Basic EPS | -42.65% | 94.26% | 93.90% | 93.82% | 94.08% |
| EPS Diluted | -185.54% | 95.39% | 94.97% | 97.84% | 97.84% |
| Normalized Diluted EPS | -42.65% | 94.26% | 93.90% | 93.82% | 94.08% |
| Average Basic Shares Outstanding | 64.33% | 2,204.32% | 2,195.52% | 2,206.18% | 1,346.70% |
| Average Diluted Shares Outstanding | 64.33% | 2,204.32% | 2,195.52% | 2,206.18% | 1,346.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |